Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimab.
Journal: Therapeutic advances in hematology
Published: March 11, 2026
Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS Study.
Journal: Therapeutic advances in hematology
Published: January 28, 2026
Management of breakthrough bleeds and surgical procedures in participants with hemophilia A or B without inhibitors receiving marstacimab prophylaxis in the phase 3 BASIS study.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 09, 2025
Marstacimab prophylaxis in hemophilia A/B without inhibitors: results from the phase 3 BASIS trial.
Journal: Blood
Published: November 19, 2024
Understanding the burden of weekly somatrogon injections compared with daily somatropin injections in children with growth hormone deficiency: a plain language summary of publication.
Journal: Therapeutic advances in endocrinology and metabolism
Published: February 24, 2024
Treatment Burden of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Randomized Study.
Journal: Journal of the Endocrine Society
Published: February 21, 2022
Safety and effectiveness of taliglucerase alfa in patients with Gaucher disease: an interim analysis of real-world data from a multinational drug registry (TALIAS).
Journal: Orphanet journal of rare diseases
Published: December 20, 2021
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY.
Journal: European journal of endocrinology
Published: March 10, 2021
Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults.
Journal: The patient
Published: January 21, 2020
Factors Driving Patient Preferences for Growth Hormone Deficiency (GHD) Injection Regimen and Injection Device Features: A Discrete Choice Experiment.
Journal: Patient preference and adherence
Published: November 19, 2019
Last Updated: 09/26/2026